Through an integrated analysis of transcriptomics data, we identified a special subgroup of EMP1+/COL3A1+ fibroblasts that are enriched in breast cancer BoM samples, which might facilitate the BoM process through interacting with tumor cells via COL3A1-ADGRG1 communication. The gene discussed is COL3A1; the disease is breast carcinoma.